TWI823853B - 敏化劑用於製備藥物的用途 - Google Patents

敏化劑用於製備藥物的用途 Download PDF

Info

Publication number
TWI823853B
TWI823853B TW107120417A TW107120417A TWI823853B TW I823853 B TWI823853 B TW I823853B TW 107120417 A TW107120417 A TW 107120417A TW 107120417 A TW107120417 A TW 107120417A TW I823853 B TWI823853 B TW I823853B
Authority
TW
Taiwan
Prior art keywords
selenium
fish oil
cells
cell proliferation
cancer cells
Prior art date
Application number
TW107120417A
Other languages
English (en)
Chinese (zh)
Other versions
TW201902492A (zh
Inventor
滉 夏
Original Assignee
夏滉
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 夏滉 filed Critical 夏滉
Publication of TW201902492A publication Critical patent/TW201902492A/zh
Application granted granted Critical
Publication of TWI823853B publication Critical patent/TWI823853B/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
TW107120417A 2017-06-13 2018-06-13 敏化劑用於製備藥物的用途 TWI823853B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762519090P 2017-06-13 2017-06-13
US62/519,090 2017-06-13

Publications (2)

Publication Number Publication Date
TW201902492A TW201902492A (zh) 2019-01-16
TWI823853B true TWI823853B (zh) 2023-12-01

Family

ID=64562472

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107120417A TWI823853B (zh) 2017-06-13 2018-06-13 敏化劑用於製備藥物的用途

Country Status (9)

Country Link
US (3) US10905724B2 (enExample)
EP (1) EP3638270B1 (enExample)
JP (2) JP7336994B2 (enExample)
KR (1) KR102773006B1 (enExample)
CN (2) CN120695037A (enExample)
CA (1) CA3066742A1 (enExample)
IL (1) IL271327B2 (enExample)
TW (1) TWI823853B (enExample)
WO (1) WO2018231938A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11206861B2 (en) * 2016-10-03 2021-12-28 Houn Simon Hsia Compositions and methods for enhancing cancer radiotherapy
TWI823853B (zh) 2017-06-13 2023-12-01 夏滉 敏化劑用於製備藥物的用途
KR20220003528A (ko) * 2019-04-01 2022-01-10 호운 사이먼 샤 암 면역요법을 위한 조성물 및 방법
US20210393579A1 (en) * 2020-06-23 2021-12-23 Zestt Wellness Limited Anthocyanin and Quercetin Based Formulations for Improved Respiratory Health
CN115462488B (zh) * 2022-10-08 2024-01-16 河南师范大学 鞣花酸作为饲料添加剂的应用，功能性饲料及制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050013875A1 (en) * 2001-10-25 2005-01-20 Takeshi Kobayashi Immunopotentiators in thermotherapy for cancer
US20160317593A1 (en) * 2013-03-28 2016-11-03 Houn Simon Hsia Nutritional composition

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US988092A (en) * 1909-11-22 1911-03-28 Celfor Tool Company Drill.
US4348483A (en) 1981-01-23 1982-09-07 Universal Foods Corporation Method for the production of chromium yeast
US4569836A (en) * 1981-08-27 1986-02-11 Gordon Robert T Cancer treatment by intracellular hyperthermia
CA2010511A1 (en) * 1989-03-01 1990-09-01 Roberto L. Ceriani Method of enhancing cancer therapy by administration of unsaturated fatty acids
NZ248605A (en) 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
US20020010144A1 (en) 1994-04-29 2002-01-24 Robert Sobol Enhancing the sensitivity of tumor cells to therapies
US5976548A (en) 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US6440464B1 (en) 1996-06-10 2002-08-27 Viva Life Science Nutritive composition for cardiovascular health containing fish oil, garlic, rutin, capsaicin, selenium, vitamins and juice concentrates
US6197295B1 (en) 1996-09-25 2001-03-06 Viva America Marketing Corporation Dietary supplementation with, and methods for administration of yeast-derived selenium product
US5810888A (en) 1997-06-26 1998-09-22 Massachusetts Institute Of Technology Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery
EP1100517A1 (en) 1998-08-04 2001-05-23 John V. Kosbab Nutrient and therapeutic compositions for the treatment of cancer
AU5319499A (en) * 1999-07-22 2001-02-13 Ivan L. Cameron Fatty acids to minimize cancer therapy side effects
US7569551B2 (en) 2000-02-25 2009-08-04 The University Of British Columbia Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
EP1383573A4 (en) * 2001-03-26 2005-09-14 Ellen A Inc METHOD AND DEVICE FOR THE TREATMENT OF ANGRYED TISSUE
US7731648B2 (en) 2001-07-25 2010-06-08 Aduro Biotech Magnetic nanoscale particle compositions, and therapeutic methods related thereto
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
US7744930B2 (en) 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US8663679B2 (en) * 2004-04-29 2014-03-04 Abbott Laboratories Compositions for improving breast health in women
US9107864B2 (en) * 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US20060088574A1 (en) 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
US20070116802A1 (en) 2005-11-23 2007-05-24 Carl Germano High quality caloric composition
US8017147B2 (en) 2008-04-07 2011-09-13 Mazed Mohammad A Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
US20090110674A1 (en) 2007-10-24 2009-04-30 Loizou Nicos C Health supplement
EP2242539B1 (en) 2008-01-16 2015-04-01 Nanospectra Biosciences, Inc. Nanoparticles for focused hyperthermia to increase efficacy of radiation therapy
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
WO2010026638A1 (ja) 2008-09-04 2010-03-11 株式会社ナノセラピー研究所 抗制御性ｔ細胞抗体と磁性微粒子を含む悪性腫瘍の温熱治療用キット、及びその温熱治療法
AU2009293475A1 (en) 2008-09-19 2010-03-25 Nestec S.A. Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment
US8257694B2 (en) 2009-05-14 2012-09-04 Product Partners, Llc Nutritional compositions for reducing oxidative damage
AU2010253968B2 (en) * 2009-05-29 2016-07-28 Board Of Regents Of The University Of Texas System Compositions and methods for modulating lipid composition
KR101275724B1 (ko) 2009-12-09 2013-06-17 한국전자통신연구원 단일 기판 집적 회로 장치 및 그 제조 방법
WO2011094579A2 (en) 2010-01-29 2011-08-04 New Chapter Inc. Mushroom compositions and methods for making and using
WO2011115062A1 (ja) 2010-03-15 2011-09-22 国立大学法人 岡山大学 抗腫瘍作用補助剤
US20120010688A1 (en) 2010-07-09 2012-01-12 Lamb Karl J Implantable conductive element and method of use inhyperthermic treatment
WO2012018597A2 (en) * 2010-07-26 2012-02-09 Chemotherapeutics, Llc Compositions and methods for enhancing the effectiveness of systemic, hipec, ip, and related cancer treatments
WO2012018595A2 (en) 2010-07-26 2012-02-09 Laird Technologies, Inc. Process for the fabrication of highly electrically- conductive polymer foams with controlled compression set suitable for use in emi shielding applications
US9642925B2 (en) 2010-12-07 2017-05-09 Sanford Research/USD Magnetic nanoparticle formulations, methods for making such formulations, and methods for their use
WO2012122295A2 (en) 2011-03-07 2012-09-13 Ned Biosystems, Inc. Treatment for pancreatic adenocarcinoma and other cancers of epithelial origin
CN102349699B (zh) 2011-07-04 2013-07-03 郑俊祥 一种电子烟液的制备方法
US9609457B2 (en) 2012-07-27 2017-03-28 Crexendo, Inc. Mobile application procurement and configuration options for VOIP service
KR101868675B1 (ko) 2012-10-05 2018-06-18 연세대학교 산학협력단 민감화 물질을 포함하는 온열 치료용 조성물
US9072768B2 (en) 2013-01-22 2015-07-07 Kibow Biotech, Inc. Composition and method for increasing effectiveness of radiation or chemotherapy
US9107947B2 (en) * 2013-01-31 2015-08-18 The Penn State Research Foundation Anti-cancer compositions and methods
WO2014159851A2 (en) * 2013-03-13 2014-10-02 The Board Of Regents Of The University Of Texas System Novel low density lipoprotein nanocarriers for targeted delevery of omega-3 polyunsaturated fatty acids to cancer
DE202013002760U1 (de) 2013-03-21 2014-06-23 Cc Pharma Gmbh Nahrungsergänzungsmittel zur medikationsorientierten Supplementierung
ES2753387T3 (es) * 2013-04-22 2020-04-08 Smartfish As Uso de una composición que comprende aceite de pescado y zumo para el tratamiento y/o tratamiento posterior del cáncer
JP2016531114A (ja) 2013-07-31 2016-10-06 株式会社明治 腫瘍の成長を阻止する栄養組成物
WO2015021936A1 (en) 2013-08-16 2015-02-19 The University Of Hong Kong Method and compositions for treating cancer using probiotics cross-reference to related application
CN104082736A (zh) * 2014-06-13 2014-10-08 胡安然 一种调理乳腺癌的方便食品
US20170246136A1 (en) * 2014-09-24 2017-08-31 OliVentures, Inc. Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases
CN105641000A (zh) * 2015-06-01 2016-06-08 深圳市康道生物有限公司 一种含灰树花提取物的抗肿瘤组合物及其制备方法
CN108472322A (zh) 2015-11-18 2018-08-31 赛贝格咨询有限责任公司 含有天然提取物的组合物以及它们在皮肤和毛发中的用途
CN105617358A (zh) * 2015-12-29 2016-06-01 广州市戴菊科技发展有限公司 一种具有抗肿瘤功能的医用食品及其制备方法
CN105768108A (zh) 2016-03-10 2016-07-20 福格森（武汉）生物科技股份有限公司 一种适用于肿瘤患者服用的特膳食品
JP6376186B2 (ja) 2016-08-04 2018-08-22 トヨタ自動車株式会社 サスペンションメンバ
US11206861B2 (en) 2016-10-03 2021-12-28 Houn Simon Hsia Compositions and methods for enhancing cancer radiotherapy
CN106822560A (zh) 2017-04-07 2017-06-13 湖北工程学院 药物组合物及其制备方法
CN111556754A (zh) 2017-06-13 2020-08-18 夏滉 增强癌症化学疗法的组合物和方法
TWI823853B (zh) 2017-06-13 2023-12-01 夏滉 敏化劑用於製備藥物的用途
KR102775757B1 (ko) 2017-06-13 2025-02-28 호운 사이먼 샤 암 방사선요법을 향상시키기 위한 조성물 및 방법
JP2020121479A (ja) 2019-01-30 2020-08-13 オリンパス株式会社 射出成形金型

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050013875A1 (en) * 2001-10-25 2005-01-20 Takeshi Kobayashi Immunopotentiators in thermotherapy for cancer
US20160317593A1 (en) * 2013-03-28 2016-11-03 Houn Simon Hsia Nutritional composition

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
網路文獻 2014年，台灣醫界，劉博仁 張金堅2014, Vol.57, No.5，營養醫學與癌症 *
網路文獻 2014年7月，余雯雅，國立海洋大學，利用小鼠結腸癌類幹細胞之動物模式及評估其特性並探討魚油合併硒酵母營養介入之影響 *
網路文獻 2016年3月1日，EHIME MEDICAL JOURNAL，Yuki Miyauchi，Antitumor effects of heating on human renal cancer cells in vivo *
網路文獻 2016年3月1日，EHIME MEDICAL JOURNAL，Yuki Miyauchi，Antitumor effects of heating on human renal cancer cells in vivo。

Also Published As

Publication number Publication date
IL271327A (en) 2020-01-30
EP3638270B1 (en) 2023-10-25
EP3638270A1 (en) 2020-04-22
US10905724B2 (en) 2021-02-02
KR20200078468A (ko) 2020-07-01
JP7336994B2 (ja) 2023-09-01
IL271327B1 (en) 2024-07-01
JP2023105154A (ja) 2023-07-28
US20220354903A1 (en) 2022-11-10
JP2020523375A (ja) 2020-08-06
US11896624B2 (en) 2024-02-13
CN111479578A (zh) 2020-07-31
IL271327B2 (en) 2024-11-01
US11433105B2 (en) 2022-09-06
WO2018231938A1 (en) 2018-12-20
CA3066742A1 (en) 2018-12-20
EP3638270A4 (en) 2021-06-30
US20180353550A1 (en) 2018-12-13
CN120695037A (zh) 2025-09-26
US20210154241A1 (en) 2021-05-27
TW201902492A (zh) 2019-01-16
KR102773006B1 (ko) 2025-02-24

Similar Documents

Publication Publication Date Title
TWI823853B (zh) 敏化劑用於製備藥物的用途
ES3013603T3 (en) A composition for weight loss or weight management comprising beta-hydroxybutyrate and cannabidiol
CN100355420C (zh) 富含亮氨酸的营养组合物
Prasad Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity
JP2009533342A (ja) シトルリンを使用する治療
WO2011091019A1 (en) Methods and compositions for treating and preventing parenteral nutrition associated liver disease
AU2020200726A1 (en) Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues
TW201902533A (zh) 用於增進癌症放射線療法之組合物及方法
WO2001006983A2 (en) Fatty acids to minimize cancer therapy side effects
JP2018076320A (ja) 糖尿病性潰瘍を治療する際に使用するための、ベータ−ヒドロキシ−ベータ−メチルブチレート、アルギニンおよびグルタミンの組合せ
US20030068385A1 (en) Accelerated action fatty acid (AAFA) promotes health of normal tissues and minimizes the toxic side effects of chemotherapy
CN1917868B (zh) 包含l-丝氨酸、l-异亮氨酸、叶酸和痕量元素的用于治疗银屑病的组合物
HK40031147A (en) Compositions and methods for enhancing hyperthermia therapy
RU2335927C2 (ru) Обогащенные лейцином питательные композиции
CN1434710A (zh) 爱滋病特效药
Ogilvie Nutrition and cancer frontiers for cure
EP3842038A1 (en) Microencapsulated formulation comprising iron and cysteine
WO2018148930A1 (zh) Nadh或者fadh2在癌症病人的营养干预上的应用
TWM603762U (zh) 男性保健膠囊之構造
ES2208131A1 (es) Metodo para la fabricacion de un medicamento reductor de nivels de lipidos en sangre para la administracion oral.
HK1108563B (zh) 富含亮氨酸的营养组合物
BRPI0904111A2 (pt) produto natural para controle de diabetes